DOXGX | GRGTX | DOXGX / GRGTX | |
Total Expense Ratio | 0.41 | 0.75 | 55% |
Annual Report Gross Expense Ratio | 0.46 | 0.95 | 48% |
Fund Existence | 3 years | 18 years | - |
Gain YTD | 9.292 | 9.370 | 99% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 116B | 416M | 27,885% |
Annual Yield % from dividends | 1.43 | 1.42 | 100% |
Returns for 1 year | 5.50 | 3.60 | 153% |
Returns for 3 years | 34.49 | 25.39 | 136% |
Returns for 5 years | N/A | 42.43 | - |
Returns for 10 years | N/A | 92.45 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
THNR | 23.40 | 0.16 | +0.68% |
Amplify Weight Loss Drug & Treatment ETF | |||
EAOK | 26.96 | N/A | N/A |
iShares ESG Aware 30/70 Cnsrv Allc ETF | |||
DNOV | 46.11 | -0.05 | -0.11% |
FT Vest US Equity Deep Bffr ETF Nov | |||
REVS | 27.65 | -0.04 | -0.16% |
Columbia Research Enhanced Value ETF | |||
TMFC | 67.96 | -0.19 | -0.28% |
Motley Fool 100 ETF |